Medication Affordability and Patent Integrity Act

Bill 118 s 2780, also known as the Medication Affordability and Patent Integrity Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to address the rising costs of prescription medications and to ensure that patents are not being abused to prevent competition and keep prices high.

One key provision of the bill is the establishment of a Prescription Drug Affordability Board, which would be responsible for setting limits on the prices of certain medications. This board would take into account factors such as the cost of production, the value of the medication to patients, and the prices of similar medications in other countries.

Another important aspect of the bill is the strengthening of patent laws to prevent pharmaceutical companies from extending their patents beyond what is necessary to recoup their research and development costs. This would help to promote competition in the pharmaceutical industry and lower prices for consumers. Overall, the Medication Affordability and Patent Integrity Act aims to make prescription medications more affordable for all Americans by addressing the root causes of high drug prices. It is currently being debated in Congress, and its passage could have a significant impact on the healthcare system in the United States.